Blackstone Inc’s Tourmaline Bio TRML Stock Holding History

Blackstone Inc’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-808,932	Closed	-$22.7M	–	179
2023 Q3	$22.7M	Hold	808,932	–	–	0.1%	60
2023 Q2	$24.6M	Hold	808,932	–	–	0.11%	55
2023 Q1	$15.2M	Hold	808,932	–	–	0.06%	67
2022 Q4	$8.25M	Hold	808,932	–	–	0.03%	73
2022 Q3	$21.3M	Hold	808,932	–	–	0.08%	54
2022 Q2	$36.5M	Hold	808,932	–	–	0.12%	49
2022 Q1	$79.6M	Hold	808,932	–	–	0.2%	47
2021 Q4	$124M	Hold	808,932	–	–	0.31%	44
2021 Q3	$110M	Hold	808,932	–	–	0.24%	50
2021 Q2	$119M	Buy	+808,932	New	+$124M	0.27%	44

Other funds holding TRML

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Blackstone Inc's TRML Position: Q4 2023 in Review

Blackstone Inc sold out of Tourmaline Bio (TRML) in Q4 2023, closing a stake of 808,932 shares — an estimated $22.7M sold.

Blackstone Inc first reported a position in TRML in Q2 2021 and held it in 10 quarters. The position peaked at $124M in Q4 2021. 54 funds tracked by Wall St. Rank hold TRML as of Q4 2023.

Blackstone Inc reported no remaining Tourmaline Bio position as of Q4 2023 after selling out during the quarter.
Blackstone Inc sold 808,932 Tourmaline Bio shares in Q4 2023, an estimated $22.7M.
Blackstone Inc first reported a position in Tourmaline Bio in Q2 2021 and held it in 10 quarters.
Blackstone Inc's Tourmaline Bio position peaked at $124M in Q4 2021.
54 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2023.

Based on Blackstone Inc's 13F filing for Q4 2023, filed 14 Feb 2024.